Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark F Bird

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Current Opinion in Supportive and Palliative Care|April 15, 2015
Simultaneous targeting of multiple opioid receptor typesMark F Bird, David G Lambert
Handbook of Experimental Pharmacology|February 17, 2019
N/OFQ-NOP System in Peripheral and Central ImmunomodulationSalim Kadhim, Mark F Bird, David G Lambert
BJA Open|August 17, 2023
Opioids and cancer survival: are we looking in the wrong place?Despina Giakomidi, Mark F Bird, David G Lambert
Journal of Pharmacological and Toxicological Methods|November 3, 2021
Fluorescent opioid receptor ligands as tools to study opioid receptor functionDespina Giakomidi, Mark F Bird, Remo Guerrini, et al.
Biochemical Pharmacology|November 28, 2025
Differential opioid receptor expression and biochemical coupling profiles on gliaSalim F Kadhim, John McDonald, Mark F Bird, et al.
British Journal of Pharmacology|April 6, 2023
In vitro sepsis up-regulates Nociceptin/Orphanin FQ receptor expression and function on human T- but not B-cellsMark F Bird, Christopher P Hebbes, Anushuya Tamang, et al.
Plos One|April 23, 2021
Evaluation of [Cys(ATTO 488)8]Dermorphin-NH2 as a novel tool for the study of μ-opioid peptide receptorsDespina Giakomidi, Mark F Bird, John McDonald, et al.
Pharmacology Research & Perspectives|August 15, 2017
In vitro pharmacological characterization of a novel unbiased NOP receptor-selective nonpeptide agonist AT-403Federica Ferrari, Davide Malfacini, Blair V Journigan, et al.
Plos One|September 15, 2022
In vitro sepsis induces Nociceptin/Orphanin FQ receptor (NOP) expression in primary human vascular endothelial but not smooth muscle cellsMark F Bird, Barbara Gallacher-Horley, John McDonald, et al.
European Journal of Pharmacology|November 23, 2016
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt<sup>1</sup>]N/OFQ(1-13)Maria Camilla Cerlesi, Huiping Ding, Mark F Bird, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Current Opinion in Supportive and Palliative Care|April 15, 2015
Simultaneous targeting of multiple opioid receptor typesMark F Bird, David G Lambert
Handbook of Experimental Pharmacology|February 17, 2019
N/OFQ-NOP System in Peripheral and Central ImmunomodulationSalim Kadhim, Mark F Bird, David G Lambert
BJA Open|August 17, 2023
Opioids and cancer survival: are we looking in the wrong place?Despina Giakomidi, Mark F Bird, David G Lambert
Journal of Pharmacological and Toxicological Methods|November 3, 2021
Fluorescent opioid receptor ligands as tools to study opioid receptor functionDespina Giakomidi, Mark F Bird, Remo Guerrini, et al.
Biochemical Pharmacology|November 28, 2025
Differential opioid receptor expression and biochemical coupling profiles on gliaSalim F Kadhim, John McDonald, Mark F Bird, et al.
British Journal of Pharmacology|April 6, 2023
In vitro sepsis up-regulates Nociceptin/Orphanin FQ receptor expression and function on human T- but not B-cellsMark F Bird, Christopher P Hebbes, Anushuya Tamang, et al.
Plos One|April 23, 2021
Evaluation of [Cys(ATTO 488)8]Dermorphin-NH2 as a novel tool for the study of μ-opioid peptide receptorsDespina Giakomidi, Mark F Bird, John McDonald, et al.
Pharmacology Research & Perspectives|August 15, 2017
In vitro pharmacological characterization of a novel unbiased NOP receptor-selective nonpeptide agonist AT-403Federica Ferrari, Davide Malfacini, Blair V Journigan, et al.
Plos One|September 15, 2022
In vitro sepsis induces Nociceptin/Orphanin FQ receptor (NOP) expression in primary human vascular endothelial but not smooth muscle cellsMark F Bird, Barbara Gallacher-Horley, John McDonald, et al.
European Journal of Pharmacology|November 23, 2016
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt<sup>1</sup>]N/OFQ(1-13)Maria Camilla Cerlesi, Huiping Ding, Mark F Bird, et al.
Pageof 2